Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;169(3):52.
doi: 10.1007/s00705-024-05995-8.

Antiviral alternatives against important members of the subfamily Parvovirinae: a review

Tamiris Silva Lopes  1 , Vagner Ricardo Lunge  1 , André Felipe Streck  2
Affiliations
Review

Antiviral alternatives against important members of the subfamily Parvovirinae: a review

Tamiris Silva Lopes et al. Arch Virol. .

Erratum in

Abstract

Parvoviruses are responsible for multiple diseases, and there is a critical need for effective antiviral therapies. Specific antiviral treatments for parvovirus infections are currently lacking, and the available options are mostly supportive and symptomatic. In recent years, significant research efforts have been directed toward understanding the molecular mechanisms of parvovirus replication and identifying potential targets for antiviral interventions. This review highlights the structure, pathogenesis, and treatment options for major viruses of the subfamily Parvovirinae, such as parvovirus B19 (B19V), canine parvovirus type 2 (CPV-2), and porcine parvovirus (PPV) and also describes different approaches in the development of antiviral alternatives against parvovirus, including drug repurposing, serendipity, and computational tools (molecular docking and artificial intelligence) in drug discovery. These advances greatly increase the likelihood of discoveries that will lead to potent antiviral strategies against different parvovirus infections.

Keywords: Treatments; canine parvovirus; parvovirus B19; pathogenesis; porcine parvovirus.

PubMed Disclaimer

References

    1. Gallinella G (2019) New insights into parvovirus research. Viruses 11(11):1053. https://doi.org/10.3390/v11111053 - DOI - PubMed - PMC
    1. Gallinella G (2013) Parvovirus B19 achievements and challenges. ISRN Virol 1–33. https://doi.org/10.5402/2013/898730
    1. Mietzsch M, Pénzes JJ, Agbandje-McKenna M (2019) Twenty-five years of structural parvovirology. Viruses 11(4):362. https://doi.org/10.3390/v11040362 - DOI - PubMed - PMC
    1. Cotmore SF, Agbandje-McKenna M, Canuti M, Chiorini JA, Eis-Hubinger AM, Hughes J, Mietzsch M, Modha S, Ogliastro M, Pénzes JJ, Pintel DJ, Qiu J, Soderlund-Venermo M, Tattersall P, Tijssen P (2019) ICTV virus taxonomy profile: Parvoviridae. J Gen Virol 100(3):367–368. https://doi.org/10.1099/jgv.0.001212 - DOI - PubMed - PMC
    1. Capozza P, Buonavoglia A, Pratelli A, Martella V, Decaro N (2023) Old and novel enteric parvoviruses of dogs. Pathogens 12(5):722. https://doi.org/10.3390/pathogens12050722 - DOI - PubMed - PMC

Substances

LinkOut - more resources